* If you want to update the article please login/register
Purpose: Objectives: To explore another option for a controlled ovarian stimulation therapy protocol that does not raise significant ovarian hyperstimulation syndrome risk among polycystic ovarian syndrome patients with specific medical characteristics. Significant OHSS incidence was higher in group 2 than group 1, and higher serum AMH level subgroups; no difference was observed between group 2 and group 1; however, there was no difference in serious OHSS risk in group 2; however, a difference in severe OHSS risk was not present. Conclusions From this limited research, a follicular-phase GnRH agonist therapy may be another option that does not raise the risk of severe OHSS in PCOS patients with lower bLH/FSH levels and lower serum AMH levels may be another option that does not raise the risk of severe OHSS.
Source link: https://europepmc.org/article/MED/35757417
Background The primary cause of Sju00f6gren syndrome is a chronic autoimmune disease with the primary target being exocrine glands, and it is the connective tissue disease more common with other autoimmune disorders. The aim of this research was to determine the prevalence of another autoimmune rheumatic disease in primary Sju00f6gren syndrome patients and to describe the disease's clinical, serological, and histologic characteristics. 30 patients experienced a second ARD during the follow-up; the most common being rheumatoid arthritis. 96% of these 30 patients had xerophthalmia, 86. 2% xerostomia, 92% positive Schirmer test, 89. 2 percent positive Rosa Bengala scale, lisamine green or Ocular Staining Score, 83. 2 percent positive unstimulated salivary flow, 82% positive sweat analysis, 81% Ro and 33. 3 percent La, 82. 6% La. When comparing the patients who developed another ARD to those that did not, there were no statistically significant differences in baseline characteristics.
Source link: https://europepmc.org/article/MED/35672809
SARS-CoV-2 disease is often associated with fever and respiratory signs. In addition to this, COVID-19-related central and peripheral nervous system manifestations are emerging. In a substantial number of patients with COVID-19-related GBS and its variants, this report summarizes the demographics, clinical profile, laboratory findings, leadership techniques, and outcomes. We also compared its medical results with Zika and dengue virus-related GBS. The research found 54 different types of journals containing 70 cases from 17 countries around the world. The gender group of more than 60 years had the largest number of 32 cases in 32 years, followed by the age group 40-60 with cases 25 with male and female ratio 2. Maximum cases were treated with IVIG infusion 58, followed by a plasma exchange 13 cases. Out of 70 cases, 7 cases were diagnosed as Miller-Fisher syndrome. With a happier result, Covid 19 related GBS were widely distributed around the world.
Source link: https://europepmc.org/article/MED/35507796
Adams-Oliver syndrome is a congenital disorder in which the principal findings are aplasia cutis congenita of the scalp and a terminal transverse limb anomaly. We have a newborn with a pronounced phenotype of Adams-Oliver syndrome. This report reveals a previously unpublished severe AOS phenotype in a term newborn. There are some evidences that the disease has progressed beyond the first trimester, whether spontaneously or by SARS-CoV-2's immune mechanisms.
Source link: https://europepmc.org/article/MED/35414337
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions